Search


 
Results 41 - 50 of about 95 for "FDA update".

Alert on canagliflozin and amputations | ACP Diabetes ...

An ongoing clinical trial found an increase in leg and foot amputations, mostly affecting the toes, in patients treated with canagliflozin (Invokana, Invokamet ...

Recall, warning, and a new generic drug | ACP Diabetes ...

Insulin cartridge holders were recalled, patients were warned about pre-owned test strips, and a generic form of rosiglitazone maleate and metformin ...

Follow-on insulin lispro approved | ACP Diabetes Monthly

The injection is approved to improve glucose control in patients ages three years and older with type 1 diabetes and in adult patients with type 2 diabetes ...

Hemoglobin A1c test approved for diagnosis | ACP Diabetes ...

The FDA recently approved the first hemoglobin A1c (HbA1c) test specifically labeled for diagnosing diabetes.

August 9, 2013 | ACP Diabetes Monthly

... to episodes of hyperglycemia. FDA update. Hemoglobin A1c test approved for diagnosis. The FDA recently approved the ...

Metformin solution recalled due to contamination | ACP ...

Two lots of metformin hydrochloride oral solution (Riomet), 500 mg/5 mL, were recalled due to fungal contamination, the FDA said.

October 12, 2012 | ACP Diabetes Monthly

... Pre-established goals and a good admission history can improve their care. FDA update. Another weight loss drug approved. ...

March 13, 2015 | ACP Diabetes Monthly

... goals, according to a study. FDA update. New labels warn against sharing multi-dose insulin pens. In an effort to reduce ...

September 16, 2016 | ACP Diabetes Monthly

... intervention to improve HbA1c testing. FDA update. Glucagon recalled due to detaching needles. Six batches of GlucaGen HypoKit ...

June 12, 2015 | ACP Diabetes Monthly

... recent analysis has found. FDA update. SGLT2 inhibitors associated with ketoacidosis. Sodium-glucose cotransporter-2 ...

Result Page: < Previous  1 2 3 4 5 6 7 8 9  Next >